On September 16, 2024, CSPC Pharma submitted a new share change report, disclosing the share repurchase situation of the company. According to the report, CSPC Pharma conducted multiple share repurchases through the Hong Kong Stock Exchange from August 23 to September 16, 2024, and plans to cancel these shares. The total number of repurchased shares reached 193,770,000 shares, accounting for 1.629% of the issued shares (excluding treasury shares) on that day. The latest repurchase occurred on September 16, 2024, with 10,684,000 shares repurchased, and the total payment amount was 49,328,120 Hong Kong dollars. In addition, the company confirmed the number of shares repurchased and the relevant repurchase prices on the Hong Kong Stock Exchange or other stock exchanges in accordance with the repurchase authorization. CSPC Pharma stated that the share repurchase action was carried out in accordance with the relevant rules of the Hong Kong Stock Exchange and did not involve any significant changes.

On September 16, 2024, CSPC Pharma submitted a new share change report, disclosing the share repurchase situation of the company. According to the report, CSPC Pharma conducted multiple share repurchases through the Hong Kong Stock Exchange from August 23 to September 16, 2024, and plans to cancel these shares. The total number of repurchased shares reached 193,770,000 shares, accounting for 1.629% of the issued shares (excluding treasury shares) on that day. The latest repurchase occurred on September 16, 2024, with 10,684,000 shares repurchased, and the total payment amount was 49,328,120 Hong Kong dollars. In addition, the company confirmed the number of shares repurchased and the relevant repurchase prices on the Hong Kong Stock Exchange or other stock exchanges in accordance with the repurchase authorization. CSPC Pharma stated that the share repurchase action was carried out in accordance with the relevant rules of the Hong Kong Stock Exchange and did not involve any significant changes.